Aaron S. Anderson

Waveguide-Based Biosensors for Pathogen Detection

Optical phenomena such as fluorescence, phosphorescence, polarization, interference and non-linearity have been extensively used for biosensing applications. Optical waveguides (both planar and fiber-optic) are comprised of a material with high permittivity/high refractive index surrounded on all sides by materials with lower refractive indices, such as a substrate and the media to be sensed. This arrangement allows coupled light to propagate through the high refractive index waveguide by total internal reflection and generates an electromagnetic wave—the evanescent field—whose amplitude decreases exponentially as the distance from the surface increases. Excitation of fluorophores within the evanescent wave allows for sensitive detection while minimizing background fluorescence from complex, “dirty” biological samples. In this review, we will describe the basic principles, advantages and disadvantages of planar optical waveguide-based biodetection technologies. This discussion will include already commercialized technologies (e.g., Corning’s EPIC® Ô, SRU Biosystems’ BIND™, Zeptosense®, etc.) and new technologies that are under research and development. We will also review differing assay approaches for the detection of various biomolecules, as well as the thin-film coatings that are often required for waveguide functionalization and effective detection. Finally, we will discuss reverse-symmetry waveguides, resonant waveguide grating sensors and metal-clad leaky waveguides as alternative signal transducers in optical biosensing.

Optimizing a Waveguide-Based Sandwich Immunoassay for Tumor Biomarkers: Evaluating Fluorescent Labels and Functional Surfaces

The sensor team at the Los Alamos National Laboratory has developed a waveguide-based optical biosensor for the detection of biomarkers associated with disease. We have previously demonstrated the application of this technology to the sensitive detection of carcinoembryonic antigen in serum and nipple aspirate fluid from breast cancer patients. In this publication, we report improvements to this technology that will facilitate transition to a point-of-care diagnostic system and/or robust research tool. The first improvement involved replacing phospholipid bilayers used for waveguide functionalization with self-assembled monolayers. These thin films are stable, specific, and robust silane-based surfaces that reduce nonspecific binding and enhance the signal to background ratio. Second, we have explored four different fluorescent labeling paradigms to determine the optimal procedure for use in the assay. Labeling the detector antibody with an organic dye (AlexaFluor 647) in the hinge region allows for unusual signal enhancement with repeat excitation (at 635 nm) in our assay format, thereby facilitating a better signal resolution at lower concentrations of the antigen. We have also labeled the detector antibody with photostable quantum dots through either the amine groups of lysine (Fc, NH) or using a histidine tag in the hinge region of the antibody (Hinge, H). Both labeling strategies allow for acceptable signal resolution, but quantum dots show much greater resistance to photobleaching than organic dyes.

Robust Sensing Films for Pathogen Detection and Medical Diagnostics

Our team has developed polyethylene glycol (PEG)-modified, self-assembled monolayers (SAMs) for biological detection on either planar or spherical substrates, which resist non-specific binding while facilitating specific ligand attachment. The preparation and characterization of these thin films, their validation against B. anthracis protective antigen (PA) in a sandwich assay format, and the application of these thin films for quantitative analysis of several medically interesting targets (breast cancer, tuberculosis, and influenza) will be shown.

Novel optical strategies for biodetection

Although bio-detection strategies have significantly evolved in the past decade, they still suffer from many disadvantages. For one, current approaches still require confirmation of pathogen viability by culture, which is the ‘gold-standard’ method, and can take several days to result. Second, current methods typically target protein and nucleic acid signatures and cannot be applied to other biochemical categories of biomarkers (e.g.; lipidated sugars). Lipidated sugars (e.g.; lipopolysaccharide, lipoarabinomannan) are bacterial virulence factors that are significant to pathogenicity. Herein, we present two different optical strategies for biodetection to address these two limitations. We have exploited bacterial iron sequestration mechanisms to develop a simple, specific assay for the selective detection of viable bacteria, without the need for culture. We are currently working on the use of this technology for the differential detection of two different bacteria, using siderophores. Second, we have developed a novel strategy termed ‘membrane insertion’ for the detection of amphiphilic biomarkers (e.g. lipidated glycans) that cannot be detected by conventional approaches. We have extended this technology to the detection of small molecule amphiphilic virulence factors, such as phenolic glycolipid-1 from leprosy, which could not be directly detected before. Together, these strategies address two critical limitations in current biodetection approaches. We are currently working on the optimization of these methods, and their extension to real-world clinical samples.

Detection of lipopolysaccharides in serum using a waveguide-based optical biosensor

Direct ultra-sensitive detection of pathogen biomarkers in blood could provide a universal strategy for diagnosis of bacterial infections, which remain a leading cause of morbidity and mortality in many areas of the world. Many factors complicate diagnosis, including the presence of multiple co-infections in a given patient, and lack of infrastructure in rural settings. In some pediatric patients, such as those in areas with poor resources, an additional challenge exists with low sample volumes due to age and other health factors such as anemia and dehydration. Our team is working on developing novel diagnostic assays, with a waveguide-based biosensor platform, to rapidly and specifically identify pathogen biomarkers from small samples of serum or plasma, allowing for the timely and sensitive diagnosis of infection at the point of care. In addition to the platform, we have developed novel membrane insertion and lipoprotein capture assay methods, to capture lipidated pathogen biomarkers in aqueous blood, by virtue of their interactions with host lipoprotein carriers. Herein, we demonstrate our efforts to adapt the lipoprotein capture assay for the detection of small concentrations of pathogen-secreted lipopolysaccharides in aqueous blood, with the ultimate aim of diagnosing Gram-negative infections effectively.

Reagentless optical biosensor

Critical to our ability to respond effectively to a biothreat attack is the development of sensitive and specific sensor systems that can easily be used for rapid screening of potential victims for infection due to biothreat agents and detection of pathogens in the environment. To help address these needs, we have developed a Reagentless Optical Biosensor (ROB) based on protein specific assays and waveguide-based evanescent fluorescence excitation. Modeled on host pathogen interactions, the sensors membrane based assay provides rapid, sensitive detection without the addition of reagents. We report here the development of two waveguide based detection systems: a laboratory sensor test-bed system and a handheld, battery operated, prototype. Evanescent fluorescence excitation using planar optical waveguides provides spatial filtering of background auto-fluorescence found in many natural samples, thereby permitting direct analysis of complex environmental and medical samples. The waveguide based assay is fully self-contained in a small, exchangeable cartridge that is optically coupled to the sensor detection system making ROB simple to use and offering the possibility of inexpensive, disposable sensor elements. Using assays for cholera toxin we compare results using flourimetry of vesicle solutions against results for our waveguide based test-bed and prototype sensor systems.

Combined LIBS-Raman for remote detection and characterization of biological samples

Laser-Induced Breakdown Spectroscopy (LIBS) and Raman Spectroscopy have rich histories in the analysis of a wide variety of samples in both in situ and remote configurations. Our team is working on building a deployable, integrated Raman and LIBS spectrometer (RLS) for the parallel elucidation of elemental and molecular signatures under Earth and Martian surface conditions. Herein, results from remote LIBS and Raman analysis of biological samples such as amino acids, small peptides, mono- and disaccharides, and nucleic acids acquired under terrestrial and Mars conditions are reported, giving rise to some interesting differences. A library of spectra and peaks of interest were compiled, and will be used to inform the analysis of more complex systems, such as large peptides, dried bacterial spores, and biofilms. These results will be presented and future applications will be discussed, including the assembly of a combined RLS spectroscopic system and stand-off detection in a variety of environments.

SQUID-based ULF MRI and Superparamagnetic Relaxometry for Early Cancer Diagnostics

Ultra-sensitive detection and imaging of tagged tissue cells using superparamagnetic nanoparticles is a developing technique for early cancer diagnostics. SQUIDs are very suitable for such sensitive measurements. Relaxometry is used for detection of tagged cells with high specificity, as only bound nanoparticles are detected via Neel relaxation. By combining relaxometry with magnetic resonance imaging the tagged area can be imaged to provide information for the inverse problem solution. Such combination could provide both accurate localization and cell count of the tagged tissue, which would enable detection and localization of cancerous tissue at a very early disease stage.

SQUID instrumentation for early cancer diagnostics

Ultra-sensitive magnetic detection and imaging of tagged tissue cells using superparamagnetic nanoparticles is a developing technique for disease diagnosis, e.g. early cancer diagnostics. Superconducting quantum interference devices (SQUIDs) are very suitable for such sensitive measurements. Super-paramagnetic relaxometry is used for detection of targeted cells with high specificity, as only bound nanoparticles are detected via Néel relaxation. By combining relaxometry with ultra-low field magnetic resonance imaging (ULF MRI), using the same instrument, the tagged area can be imaged to provide anatomical information and bounds for the inverse problem, as the same magnetic particles work as MRI contrast agents. The combination of ULF MRI and relaxometry could provide both accurate localization and cell count of the tagged tissue, which would enable detection and localization of cancerous tissue at a very early disease stage. We describe our design of such a combined SQUID-based instrument, and present our first experimental results on phantoms.